ACTIONABILITY


Granularity, accuracy and precision of key intelligence findings

SUCCESS


Ongoing 2-way communication and exceptional delivery

APPLICABILITY


Robust, meaningful and actionable insights and intelligence

DELIVERABLES


Refined and highly synthesized work product and deliverables

We Are Experts in

“Advancing the Intelligent Choice”
– David Alderman, President Molekule Consulting, Inc

MOLEKULE’S ETHICAL APPROACH TO
STRATEGIC AND COMPETITIVE INTELLIGENCE

Molekule’s consultants engage in true “peer-to-peer” conversations with key targeted respondents as a means of gleaning insights into

competitor strategies, tactics, pricing and methodologies.

Molekule’s robust and growing organic source network spans > 20,000 contacts, globally. We foster persistent source development via active project engagement and the regular attendance of 

globalmedical congresses and biopharmaceutical trade shows.

Leveraging a robust and actively growing organic global stakeholder network, including relationships with well-placed clinical, commercial, regulatory, manufacturing and supply chain logistics sources affords Molekule Consulting the ability to comprehensively address

identified key intelligence topics and questions set forth by our client partners across all relevant proactive monitoring and responsive ad hoc research streams.

Interviews are proactively performed with key KOLs, regulators (global), payers, and other relevant industry stakeholders as a

means of developing robust competitive insights into the overarching competitive biopharmaceutical landscape.

Further responsive ad hoc interviews are performed at the request of our client partners addressing specific questions allowing defined

and granular “drill-down” into specific issues and/or queries.

infographic

WHY MOLEKULE CONSULTING?

From the moment we receive a request for proposal/quotation (“RFP”/ “RFQ”) to the fulfillment of all engagement deliverables exceeding our client partner’s satisfaction, Molekule provides world class and differentiated primary CI research and consulting to biopharmaceutical, medical device and life sciences clients, globally.

We methodically respond to RFPs in a detailed and intricate fashion, corresponding to Molekule’s commitment to robust client centricity and best-in-class primary competitive intelligence research.

Following this, we openly communicate with our prospective client partners as a means of establishing the rationale and reasoning as to why Molekule is the intelligent choice for primary CI partner.

GLOBAL GROWING AND ORGANIC

KEY OPINION LEADER (“KOL”) /

CLINICAL / ACADEMIC / MEDICAL SOURCES

International KOL

National KOL

Regional KOL

Local KOL

Academician

Physician

Scientist

Other Academic, Clinical, Scientific & Medical Sources

COMPETITOR EMPLOYEE SOURCES

(CURRENT & RECENTLY FORMER)

Sales & Marketing

Commercialization

Executive Leadership

Manufacturing

Research & Development

Clinical/Medical Affairs

Scientific Affairs

Regulatory Affairs Brand
Management/Leadership

Strategy & Operations

Management

Supply Chain/Logistics
Business Development

Market Research & Analytics

Other Competitor

Functional Roles

OTHER SOURCES

Payers

Wholesalers

Distributors

Pharmacies

Pharmacies
(Retail & Hospital)

Third-Party Enablers


REGULATOR / REGULATORY SOURCES

Global Regulators

National Regulators

Regional Regulators

Local Regulators

greenbox-1greenbox-2

Locations